SEC Filing Analysis: Hims & Hers Health, Inc. (HIMS)

Executive Summary

• Trading Significance: Low
• Key Takeaway: An officer of Hims & Hers Health, Inc. has filed a notice of a proposed sale of shares valued at approximately $112k, executed under a pre-arranged 10b5-1 trading plan.
• Market Impact: The transaction is financially immaterial and is not expected to have any impact on the stock price.

Company Information

Field	Value
Company	Hims & Hers Health, Inc.
Ticker Symbol	HIMS
CIK	0001773751
Industry	Services-Offices & Clinics of Doctors of Medicine

Insider Information

Field	Value
Name	Boughton Soleil
CIK	0001837817
Title/Position	Officer
Relationship	Officer

Transaction Details

Field	Value
Form Type	144
Transaction Date	2025-11-10
Transaction Code	S (Sale)
Security Type	Class A Common Stock
Shares Involved	2,637
Price Per Share	$42.53 (approx.)
Total Value	$112,151.61
Shares Owned After	Not Disclosed
Ownership Type	Not Disclosed

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$112,151.61
% of Market Cap	0.0012%
Shares Transacted	2,637
% of Shares Outstanding	0.0012%
Post-Transaction Ownership	Not Disclosed
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: With a market capitalization of $9.34 billion, this $112k transaction is negligible and represents a tiny fraction of the company's total value.
• Transaction Significance: The sale is considered routine and non-indicative of a change in the insider's outlook on the company, primarily due to its small size and pre-planned nature.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The transaction is extremely small relative to the company's market cap and daily trading volume. It is part of a disclosed 10b5-1 plan, which signals it is not based on new material non-public information.

Volume & Sentiment

• Expected Volume Impact: None. The size of the trade is insignificant.
• Sentiment Indicator: Neutral. The market typically ignores small, planned sales by insiders.

Additional Context

Transaction Notes

• Special Circumstances: The sale is being made pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024. The filing also discloses a pattern of similar small sales by the insider over the past three months, reinforcing the programmatic nature of these dispositions.
• Source of Shares: The shares to be sold were acquired through the vesting of restricted stock as part of the insider's compensation.